# BORTEZOMIB
> **ANDA209659** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2022-05-02
## Drug
- **FDA Application Number:** ANDA209659
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BORTEZOMIB
- **Generic name:** BORTEZOMIB
- **Active ingredients:** BORTEZOMIB
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS, SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2022-05-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209659)
---
*AI Analytics · CC0 1.0*